Motor Neurone Disease Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
Condition: Motor Neuron Disease Interventions: Drug: FLX-787-ODT (orally disintegrating tablet); Drug: Placebo ODT Sponsor: Flex Pharma, Inc. Not yet recruiting - verified June 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 20, 2017 Category: Research Source Type: clinical trials
